Appropriate regulation of cellular metabolic programs involved in energy (ATP) generation is essential for normal tissue development and homeostasis. ATP generation in heart and slow-twitch skeletal muscle involves primarily oxidative metabolism of fatty acids and glucose within the mitochondrion. The capacity for mitochondria! ATP generation and the selection of energy substrates in heart and skeletal muscle is regulated by developmental, physiological, and environmental cues that signal coordinated changes in the levels of enzymes involved these processes. Perturbations of appropriate regulation lead to changes in mitochondrial metabolism and substrate selection linked to heart and skeletal muscle insulin resistance and diabetes, heart failure and age-related declines in muscle function. Nuclear receptor (NR) transcription factors and their coactivator, PGC-1a, play a central role in regulating energy metabolism in skeletal muscle, heart, brown adipose and liver, by coordinating changes in metabolic enzyme gene expression. The estrogen-related receptors (ERR), ERRa and ERRg, have been implicated as important metabolic regulators in heart and skeletal muscle, due to their high expression in these tissues and their responsiveness to physiologic cues that increase energy metabolism. In order to understand the broad regulatory program downstream of ERRs in muscle, we propose using in vitro cell models and genetically-modified mouse models of ERRa and ERRg gain- and loss-of-function. We will analyze these models with gene expression profiling coupled with chromatin immunoprecipitation to identify target genes for ERRs. Based upon gene targets identified to date, we propose that ERRs are essential activators of heart and skeletal muscle energy metabolism that play particularly important function in developmental switches in myocyte metabolic programs. We assess the regulation of metabolism using models in which ERR isoforms are selectively activated by overexpression or inhibited by gene targeting or small-interfering RNA. The characterization of ERR function in cardiac and skeletal muscle has important implications for disease states, including heart failure and myocardial ischemia, type 2 diabetes, and obesity. Our findings will elucidate the potential for ERRs as therapeutic targets for widespread human diseases associated with metabolic dysregulation. ? ? ? ?

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Research Project (R01)
Project #
1R01DK074700-01A1
Application #
7259660
Study Section
Skeletal Muscle and Exercise Physiology Study Section (SMEP)
Program Officer
Margolis, Ronald N
Project Start
2007-07-24
Project End
2011-06-30
Budget Start
2007-07-24
Budget End
2008-06-30
Support Year
1
Fiscal Year
2007
Total Cost
$309,876
Indirect Cost
Name
City of Hope/Beckman Research Institute
Department
Type
DUNS #
027176833
City
Duarte
State
CA
Country
United States
Zip Code
91010
LaBarge, Samuel; McDonald, Marisa; Smith-Powell, Leslie et al. (2014) Estrogen-related receptor-? (ERR?) deficiency in skeletal muscle impairs regeneration in response to injury. FASEB J 28:1082-97
Murray, Jennifer; Auwerx, Johan; Huss, Janice M (2013) Impaired myogenesis in estrogen-related receptor ? (ERR?)-deficient skeletal myocytes due to oxidative stress. FASEB J 27:135-50
Murray, Jennifer; Huss, Janice M (2011) Estrogen-related receptor ? regulates skeletal myocyte differentiation via modulation of the ERK MAP kinase pathway. Am J Physiol Cell Physiol 301:C630-45
Mitra, Mayurranjan S; Schilling, Joel D; Wang, Xiaowei et al. (2011) Cardiac lipin 1 expression is regulated by the peroxisome proliferator activated receptor ? coactivator 1?/estrogen related receptor axis. J Mol Cell Cardiol 51:120-8
Tarnowski, Maciej; Grymula, Katarzyna; Reca, Ryan et al. (2010) Regulation of expression of stromal-derived factor-1 receptors: CXCR4 and CXCR7 in human rhabdomyosarcomas. Mol Cancer Res 8:1-14
Cresci, Sharon; Huss, Janice M; Beitelshees, Amber L et al. (2010) A PPAR? promoter variant impairs ERR-dependent transactivation and decreases mortality after acute coronary ischemia in patients with diabetes. PLoS One 5:e12584